As results revealed, after treatment with TPP‐LND@Lip or PD‐L1 monoclonal antibody, tumor weight was decreased by 48.4 ± 19.6% and 20.2 ± 16.1%, respectively, compared with the control group (Figure 8D). This evidence concerns the gene CD274 and neoplasm.